492 filings
10-Q
2024 Q1
DXCM
Dexcom Inc
Quarterly report
25 Apr 24
5:17pm
8-K
DXCM
Dexcom Inc
25 Apr 24
Dexcom Reports First Quarter 2024 Financial Results
4:05pm
ARS
2023 FY
DXCM
Dexcom Inc
22 Apr 24
Annual report to shareholders
4:39pm
DEF 14A
DXCM
Dexcom Inc
Definitive proxy
22 Apr 24
4:32pm
8-K
DXCM
Dexcom Inc
15 Feb 24
Entry into a Material Definitive Agreement
4:15pm
8-K
avtm3lg
8 Feb 24
Dexcom Reports Fourth Quarter and Fiscal Year 2023 Financial Results
4:03pm
8-K
w1iwvky2l 3itg1ub1
8 Jan 24
Dexcom Reports Preliminary, Unaudited Revenue for the Fourth Quarter and Fiscal Year 2023 and Initial 2024 Outlook
8:02am
8-K
evqqj5uy
2 Nov 23
Other Events
4:19pm
8-K
n0ffzio w4
26 Oct 23
Dexcom Reports Third Quarter 2023 Financial Results, Raises 2023 Revenue and Margin Guidance, and Announces $500 Million Share Repurchase Program
4:04pm
8-K
aca21
26 Oct 23
Other Events
4:04pm
8-K
mdps37e0kwf
28 Aug 23
Departure of Directors or Certain Officers
8:41am
8-K
kuj850rbq4j n08mxx
27 Jul 23
Dexcom Reports Second Quarter 2023 Financial Results
4:05pm
8-K
jmpfo7i8w2kp4b6c0
23 Jun 23
Dexcom Updates Long-Range Financial Targets
6:04pm
SD
0xftykj9bvtrtwpaz
31 May 23
Conflict minerals disclosure
4:03pm
8-K
2esrww58nev3xuqzup60
19 May 23
Departure of Directors or Certain Officers
5:01pm
8-K
gkyartuc1u7f66src
5 May 23
Entry into a Material Definitive Agreement
5:16pm
8-K
j01aos4n
3 May 23
Dexcom Prices Upsized Offering of $1.1 Billion of 0.375% Convertible Senior Notes Due 2028
7:19am